推薦產品
描述
cationic
品質等級
化驗
≥98.0% (NT)
分子量
320.00 g/mol
mp
232-237 °C
SMILES 字串
[Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C
InChI
1S/C19H42N.ClH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(2,3)4;/h5-19H2,1-4H3;1H/q+1;/p-1
InChI 密鑰
WOWHHFRSBJGXCM-UHFFFAOYSA-M
應用
十六烷基三甲基氯化铵(CTAC)是一种阳离子表面活性剂，可用于：
- 通过甲基三甲氧基硅烷(MTMS)的水解和缩聚反应制备聚甲基倍半硅氧烷(PMSQ)气凝胶。
- 鲁米诺化学发光法测定市售漱口水产品中的碘和碘化物。
- 用作模板，结合十六烷基三甲基溴化铵(CTAB)，以硅酸钠为前体制备棒状介孔二氧化硅。
- 用作由醛、丙二腈和苯酚一锅三组分反应合成2-氨基-2-色烯的催化剂。
十六烷基三甲基铵氯化物可用作合成MCM-41（41号美孚合成物）的前体，是一种通过两步溶胶-凝胶工艺室温制成的均一中孔物质。
訊號詞
Danger
危險分類
Acute Tox. 3 Dermal - Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Skin Corr. 1C
儲存類別代碼
6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
dust mask type N95 (US), Eyeshields, Gloves
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Catalytic epoxidation of unsaturated alcohols on Ti-MCM-41.
Berlini C, et al.
Catalysis Today, 60(3-4), 219-225 (2000)
Chemiluminescence determination of iodide and/or iodine using a luminol-hexadecyltrimethylammonium chloride reversed micelle system following on-line oxidation and extraction
Fujiwara T, et al.
Analyst, 125(4), 759-763 (2000)
Rifat Kamarudheen et al.
ACS nano, 12(8), 8447-8455 (2018-08-03)
The excitation of localized surface plasmon resonances in Au and Ag colloids can be used to drive the synthesis of complex nanostructures, such as anisotropic prisms, bipyramids, and core@shell nanoparticles. Yet, after two decades of research, it is challenging to
Synthesis of rod-like mesoporous silica using mixed surfactants of cetyltrimethylammonium bromide and cetyltrimethylammonium chloride as templates
Han S, et al.
Materials Letters, 57(29), 4520-4524 (2003)
Tharindu A Ranathunge et al.
Nanomaterials (Basel, Switzerland), 9(2) (2019-02-10)
Doxorubicin (DOX) is an anticancer drug commonly used in treating cancer; however, it has severe cytotoxicity effects. To overcome both the adverse effects of the drug and mineral deficiency (i.e., hypomagnesemia) experienced by cancer patients, we have developed magnesium oxide
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務